169 related articles for article (PubMed ID: 33355505)
21. Intramuscular interstitial cells of Cajal associated with mast cells survive nitrergic nerves in achalasia.
Zarate N; Wang XY; Tougas G; Anvari M; Birch D; Mearin F; Malagelada JR; Huizinga JD
Neurogastroenterol Motil; 2006 Jul; 18(7):556-68. PubMed ID: 16771771
[TBL] [Abstract][Full Text] [Related]
22. Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia.
Sridhara S; Ravi K; Smyrk TC; Kita H; Kephart GM; Weiler CR; Katzka DA
Clin Gastroenterol Hepatol; 2012 Jul; 10(7):735-41. PubMed ID: 22289868
[TBL] [Abstract][Full Text] [Related]
23. Eosinophil infiltration in primary esophageal achalasia. A possible pathogenic role.
Tøttrup A; Fredens K; Funch-Jensen P; Aggestrup S; Dahl R
Dig Dis Sci; 1989 Dec; 34(12):1894-9. PubMed ID: 2689111
[TBL] [Abstract][Full Text] [Related]
24. Single-cell RNA sequencing of mast cells in eosinophilic esophagitis reveals heterogeneity, local proliferation, and activation that persists in remission.
Ben-Baruch Morgenstern N; Ballaban AY; Wen T; Shoda T; Caldwell JM; Kliewer K; Felton JM; Abonia JP; Mukkada VA; Putnam PE; Bolton SM; Dwyer DF; Barrett NA; Rothenberg ME
J Allergy Clin Immunol; 2022 Jun; 149(6):2062-2077. PubMed ID: 35304158
[TBL] [Abstract][Full Text] [Related]
25. Neuronal Control of Esophageal Peristalsis and Its Role in Esophageal Disease.
Nikaki K; Sawada A; Ustaoglu A; Sifrim D
Curr Gastroenterol Rep; 2019 Nov; 21(11):59. PubMed ID: 31760496
[TBL] [Abstract][Full Text] [Related]
26. Disodium cromoglycate treatment reduces T
Silva FMCE; de Oliveira EE; Ambrósio MGE; Ayupe MC; de Souza VP; Menegati LM; Reis DRL; Machado MA; Macedo GC; Ferreira AP
Int Immunopharmacol; 2020 Jun; 83():106422. PubMed ID: 32251959
[TBL] [Abstract][Full Text] [Related]
27. Serum eosinophil cationic protein is superior to mast cell tryptase as marker for response to topical corticosteroid therapy in eosinophilic esophagitis.
Schlag C; Pfefferkorn S; Brockow K; Haller B; Slotta-Huspenia J; Schulz S; von Werder A; Ring J; Schmid RM; Bajbouj M
J Clin Gastroenterol; 2014 Aug; 48(7):600-6. PubMed ID: 24177377
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of esophageal rings in eosinophilic esophagitis.
Mann NS; Leung JW
Med Hypotheses; 2005; 64(3):520-3. PubMed ID: 15617859
[TBL] [Abstract][Full Text] [Related]
29. Development and Application of a Functional Human Esophageal Mucosa Explant Platform to Eosinophilic Esophagitis.
Kurten RC; Rawson R; Shoda T; Duong LD; Adejumobi D; Levy R; Newbury RO; Rothenberg ME; Akuthota P; Wright BL; Dohil R; Jones SM; Aceves SS
Sci Rep; 2019 Apr; 9(1):6206. PubMed ID: 30996235
[TBL] [Abstract][Full Text] [Related]
30. Mast cell infiltration associated with loss of interstitial cells of Cajal and neuronal degeneration in achalasia.
Liu ZQ; Chen WF; Wang Y; Xu XY; Zeng YG; Lee Dillon D; Cheng J; Xu MD; Zhong YS; Zhang YQ; Yao LQ; Zhou PH; Li QL
Neurogastroenterol Motil; 2019 May; 31(5):e13565. PubMed ID: 30868687
[TBL] [Abstract][Full Text] [Related]
31. Allergen challenge sensitizes TRPA1 in vagal sensory neurons and afferent C-fiber subtypes in guinea pig esophagus.
Liu Z; Hu Y; Yu X; Xi J; Fan X; Tse CM; Myers AC; Pasricha PJ; Li X; Yu S
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(6):G482-8. PubMed ID: 25591867
[TBL] [Abstract][Full Text] [Related]
32. Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice.
Arias Á; Lucendo AJ
Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):99-117. PubMed ID: 30791784
[TBL] [Abstract][Full Text] [Related]
33. Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations.
Spechler SJ
J Gastroenterol; 2019 Oct; 54(10):837-844. PubMed ID: 31342146
[TBL] [Abstract][Full Text] [Related]
34. Achalasia with dense eosinophilic infiltrate responds to steroid therapy.
Savarino E; Gemignani L; Zentilin P; De Bortoli N; Malesci A; Mastracci L; Fiocca R; Savarino V
Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1104-6. PubMed ID: 21839711
[TBL] [Abstract][Full Text] [Related]
35. Eosinophilic esophagitis in a patient with vigorous achalasia.
Landres RT; Kuster GG; Strum WB
Gastroenterology; 1978 Jun; 74(6):1298-1301. PubMed ID: 648822
[TBL] [Abstract][Full Text] [Related]
36. High-resolution endoluminal sonography in achalasia.
Miller LS; Liu JB; Barbarevech CA; Baranowski RJ; Dhuria M; Schiano TD; Goldberg BB; Fisher RS
Gastrointest Endosc; 1995 Dec; 42(6):545-9. PubMed ID: 8674925
[TBL] [Abstract][Full Text] [Related]
37. Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia.
Aggestrup S; Uddman R; Sundler F; Fahrenkrug J; Håkanson R; Sørensen HR; Hambraeus G
Gastroenterology; 1983 May; 84(5 Pt 1):924-7. PubMed ID: 6832568
[TBL] [Abstract][Full Text] [Related]
38. Cellular and molecular immunological mechanisms in eosinophilic esophagitis: an updated overview of their clinical implications.
Lucendo AJ
Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):669-85. PubMed ID: 24742298
[TBL] [Abstract][Full Text] [Related]
39. Achalasia: physiology and etiopathogenesis.
Kraichely RE; Farrugia G
Dis Esophagus; 2006; 19(4):213-23. PubMed ID: 16866850
[TBL] [Abstract][Full Text] [Related]
40. Achalasia: new perspectives on an old disease.
Gyawali CP
Neurogastroenterol Motil; 2016 Jan; 28(1):4-11. PubMed ID: 26690870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
